Sight Sciences, Inc.’s SGHT share price has dipped by 5.02%, which has investors questioning if this is right time to buy.

The Sustainability Report provides data for 2022 through 2024 on the Company’s environmental, social, and governance initiatives ...

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that ...

"We are very excited to add Gary to our Board of Directors,” stated Paul Badawi, Co-founder and Chief Executive Officer of ...

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients ...

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients ...

New system features higher viscoelastic capacity and TruSync™ technology, engineered to safely synchronize surgical control ...

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce ...